TY - JOUR
T1 - Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice
T2 - A randomized controlled trial
AU - Spijk-de Jonge, Marieke J.
AU - Weijers, Julia M.
AU - Teerenstra, Steven
AU - Elwyn, Glyn
AU - van de Laar, Mart A.F.J.
AU - van Riel, Piet L.C.M.
AU - Huis, Anita M.P.
AU - Hulscher, Marlies E.J.L.
N1 - Funding Information:
This work was supported by AbbVie B.V and by the Dutch Arthritis Association [grant number BP12-1-262 ]. Neither AbbVie B.V. or the Dutch Arthritis Association had any role in the design of this study, its execution, analyses, interpretation of the data, or decision to submit results.
Publisher Copyright:
© 2021 The Authors
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Objective: To evaluate the effect of an intervention to improve disease activity-based management of RA in daily clinical practice by addressing patient level barriers.Methods: The DAS-pass strategy aims to increase patients’ knowledge about DAS28 and to empower patients to be involved in treatment (decisions). It consists of an informational leaflet, a patient held record and guidance by a specialized rheumatology nurse. In a Randomized Controlled Trial, 199 RA patients were randomized 1:1 to intervention or control group. Outcome measures were patient empowerment (EC-17; primary outcome), attitudes towards medication (BMQ), disease activity (DAS28) and knowledge about DAS28.Results: Our strategy did not affect EC-17, BMQ, or DAS28 use. However it demonstrated a significant improvement of knowledge about DAS28 in the intervention group, compared to the control group. The intervention had an additional effect on patients with low baseline knowledge compared to patients with high baseline knowledge.Conclusion: The DAS-pass strategy educates patients about (the importance of) disease activity-based management, especially patients with low baseline knowledge. Practice Implications: The strategy supports patient involvement in disease activity-based management of RA and can be helpful to reduce inequalities between patients in the ability to be involved in shared decision making.
AB - Objective: To evaluate the effect of an intervention to improve disease activity-based management of RA in daily clinical practice by addressing patient level barriers.Methods: The DAS-pass strategy aims to increase patients’ knowledge about DAS28 and to empower patients to be involved in treatment (decisions). It consists of an informational leaflet, a patient held record and guidance by a specialized rheumatology nurse. In a Randomized Controlled Trial, 199 RA patients were randomized 1:1 to intervention or control group. Outcome measures were patient empowerment (EC-17; primary outcome), attitudes towards medication (BMQ), disease activity (DAS28) and knowledge about DAS28.Results: Our strategy did not affect EC-17, BMQ, or DAS28 use. However it demonstrated a significant improvement of knowledge about DAS28 in the intervention group, compared to the control group. The intervention had an additional effect on patients with low baseline knowledge compared to patients with high baseline knowledge.Conclusion: The DAS-pass strategy educates patients about (the importance of) disease activity-based management, especially patients with low baseline knowledge. Practice Implications: The strategy supports patient involvement in disease activity-based management of RA and can be helpful to reduce inequalities between patients in the ability to be involved in shared decision making.
UR - http://www.scopus.com/inward/record.url?scp=85113877593&partnerID=8YFLogxK
U2 - 10.1016/j.pec.2021.08.013
DO - 10.1016/j.pec.2021.08.013
M3 - Article
AN - SCOPUS:85113877593
VL - 105
SP - 1244
EP - 1253
JO - Patient education and counseling
JF - Patient education and counseling
SN - 0738-3991
IS - 5
ER -